Quotient Sciences
Last update: December 11, 2020
Pharmaceuticals
United Kingdom (UK)
Its 6 main executives
Create an alert
to follow the executive moves at Quotient Sciences.
Most searched biographies at Quotient Sciences
- Mark Egerton, Chief Executive Officer and Director
- Florian Kreuzer, Non-Executive Director
- Gregory Petros, Non-Executive Director
Click on an executive to view his biography >
Latest M&A news in Pharmaceuticals.
Tilray and Aphria have announced they will merge (posted on Dec 17, 2020).
AstraZeneca has announced the acquisition of Alexion Pharmaceuticals (posted on Dec 14, 2020).
Bristol-Myers Squibb has acquired MyoKardia (posted on Nov 18, 2020).
Other contacts in the Pharmaceuticals industry
Latest news about Quotient Sciences
Quotient Sciences on Wikipedia, Google News & Yahoo Finance
Quotient Sciences on LinkedIn, Twitter & YouTube
Quotient Sciences has 2,030 competitors including Johnson & Johnson (United States (USA)), Pfizer (United States (USA)) and Roche (Switzerland).
Contact by email its executives including Mark Egerton 
Call Quotient Sciences at +44 115....
